In line with this, in vivo immuno-staining of tumor sections with LC3B antibody, and increased survival in cells pretreated with 3MA confirmed our in vitro findings concerning autophagy as one of the mechanisms of cell death in glioma cells after treatment with RSV and TMZ + RSV combination therapy. The gene discussed is MAP1LC3B; the disease is central nervous system cancer.